WOLVERINE (BPC-157 + TB-500)

Description

DESCRIPTION

This research peptide blend combines BPC‑157 (10mg) and TB‑500 (10mg), two extensively studied compounds known for their roles in tissue repair, angiogenesis, cellular protection, and musculoskeletal recovery. Research models often evaluate how these peptides may complement one another, supporting regenerative signaling pathways, improved microcirculatory dynamics, and accelerated structural restoration in controlled laboratory systems.

LYOPHILYZED PEPTIDES

These peptides are freeze‑dried to maintain purity, structural integrity, and long‑term stability. No fillers or excipients are used in this lyophilization process.

RESEARCH APPLICATIONS

1 — Musculoskeletal & Soft‑Tissue Regeneration

BPC‑157 and TB‑500 are each investigated for their potential roles in soft‑tissue recovery, including tendon, ligament, muscle, and epithelial models. Studies explore their combined influence on fibroblast migration, angiogenesis, and accelerated healing responses across musculoskeletal systems.

(References: Nature—https://www.nature.com/articles/s41598-020-78676-8, PubMed—https://pubmed.ncbi.nlm.nih.gov/33135667/ )

2 — Angiogenesis & Microcirculatory Support

Both peptides have been examined for modulating blood‑flow dynamics, supporting endothelial stability, and improving microvascular function in damaged or stressed tissues. Researchers frequently evaluate synergistic effects on angiogenic signaling and vascular repair models.

(References: ScienceDirect—https://www.sciencedirect.com/science/article/pii/S0944711319302200, PubMed—https://pubmed.ncbi.nlm.nih.gov/29385773/ )

3 — Anti‑Inflammatory & Cytoprotective Pathways

Laboratory studies suggest each peptide may influence cytokine regulation, oxidative‑stress protection, and cellular stability in disrupted micro‑environments. Their combined use is often applied in research exploring multi‑level inflammation‑modulating pathways.

(References: Frontiers—https://www.frontiersin.org/articles/10.3389/fphar.2021.808770/full, PubMed—https://pubmed.ncbi.nlm.nih.gov/21262318/ )

SPECIFICATIONS

Property | Details

Blend | BPC‑157 10mg + TB‑500 10mg (20mg total)

Amino Acid Sequences | BPC‑157: Gly‑Glu‑Pro‑Pro‑Pro‑Gly‑Lys‑Pro‑Ala‑Asp‑Asp‑Ala‑Gly‑Leu‑Val; TB‑500 active region: Ac‑Ser‑Asp‑Lys‑Pro‑Asp‑Met‑Ala‑Glu‑Ile‑Glu‑Lys‑Phe‑Glu‑Lys

Appearance | White to off‑white lyophilized powder

Purity | ≥ 99% (HPLC verified)

Form | Lyophilized powder

Solubility | Soluble in bacteriostatic water

Storage | Store dry at 2–8 °C; refrigerate after reconstitution

Usage | Laboratory research only

Research Data & References

– BPC‑157 angiogenesis data: https://pubmed.ncbi.nlm.nih.gov/33135667/

– TB‑500 cytoskeletal repair studies: https://www.sciencedirect.com/science/article/pii/S0944711319302200

Disclaimer — Research Use Only

All information presented herein is intended solely for laboratory and educational research. These materials are not approved for human or veterinary use, nor for diagnostic or therapeutic application. Descriptions of biochemical activity are provided for informational context only and must not be interpreted as medical advice. Researchers are expected to handle all compounds in compliance with local regulations and institutional safety standards. EOC Labs supports responsible, ethical, and compliant scientific inquiry.